Skip to main content

Table 4 Influence of organ manifestation, BMI, age and gender on GHS

From: FeV1 and BMI influence King’s Sarcoidosis Questionnaire score in sarcoidosis patients

  Estimate CI p VIF
Eye involvement − 8.490 − 19.15 to 2.17 0.118 1.16
Liver involvement − 2.417 − 15.76 to 10.92 0.721 1.48
Lung involvement − 4.078 − 13.58 to 5.42 0.398 1.08
Skin involvement − 0.164 − 8.73 to 8.40 0.970 1.04
CNS involvement 2.077 − 9.07 to 13.23 0.713 1.11
Renal involvement − 0.448 − 12.63 to 11.73 0.942 1.04
Heart involvement − 4.250 − 21.20 to 12.70 0.621 1.04
Bone involvement − 23.064 − 37.63 to − 8.49 0.002 1.06
Joint − 12.889 − 28.74 to 2.96 0.110 1.08
Spleen involvement − 12.804 − 28.66 to 3.05 0.113 1.43
BMI − 1.076 − 1.61 to − 0.54 0.0001 1.05
Male − 5.803 − 11.75 to 0.14 0.056 1.09
Age − 0.004 − 0.23 to 0.22 0.969 1.04
  1. Adjusted R2 = 0.17, p < 0.0001 for the model
  2. Values with statistical significance defined as p < 0.05 were indicated in bold
  3. VIF Variance Inflation Factor